Altria Group, Inc. · NYSE:MO

Altria — CAGNY Conference 2014

115 slides from Altria's conference presentation, Feb 19, 2014

  1. Slide 1: 2014 CAGNY Investor Presentation

    2014 CAGNY Investor Presentation February 19, 2014

  2. Slide 2: Management Team Participants

    Management Team Participants Howard Willard – EVP and Chief Dave Beran – President and Chief Financial Officer, Altria Group, Inc. Operating Officer, Altria Group, Inc. Jim Dillard – Sr. Vice President, Murray Garnick – Sr. Vice President Regulatory Affairs, ALCS and Associate General Counsel, ALCS

  3. Slide 3: Safe Harbor Statement

    Safe Harbor Statement Statements, including earnings guidance, in this presentation that are not reported financial results or other historical information are “forward-looking statements” within the meaning of Private Securities Litigation Reform Act of 1995. Such forward-looking statements are bas

  4. Slide 4: EPS and Dividend Growth

    EPS and Dividend Growth Adjusted Diluted EPS* Dividend Per Share +7.9% +8.8% CAGR CAGR $2.38 $1.92 $1.51 $1.16 2007 2013 2007 2013 *For reconciliation of non-GAAP to GAAP measures visit altria.com Note: Annualized rate: 6-year CAGR assumes the post-PMI spin-off dividend of $0.29 per common share was

  5. Slide 5: Six-Year Total Shareholder Return

    Six-Year Total Shareholder Return 137% 44% Altria Group S&P 500 Note: Total shareholder return is simple price appreciation plus the reinvestment of the dividend as of the ex-dividend date (12/31/2007 to 12/31/2013). Source: Bloomberg Daily Return

  6. Slide 6: Long-Term Financial Goals

    Long-Term Financial Goals  Grow adjusted diluted EPS at average annual rate of 7% to 9%  Maintain a dividend payout ratio of approximately 80% of adjusted diluted EPS

  7. Slide 7: Altria's Strategies

    Altria’s Strategies Maximize income from core premium tobacco businesses over the long term Grow new income streams with innovative products Manage diverse income streams and strong balance sheet to deliver consistent financial performance

  8. Slide 8: Altria Companies' Capabilities

    Altria Companies’ Capabilities  Deeply understanding adult tobacco consumers  Building and sustaining premium brands  Creating strong sales and distribution relationships  Developing innovative products  Managing external challenges facing our businesses

  9. Slide 9: Agenda

    Agenda  Maximizing income from our core tobacco businesses  Approach to innovation  Diverse business model and strong balance sheet  Regulatory capabilities  Delivering shareholder returns

  10. Slide 10: Tobacco Industry Manufacturers' Profit Pool

    Tobacco Industry Manufacturers’ Profit Pool $ in Billions ~+5% $16 $14.5 CAGR $11.4 $0 2008 2013 Source: Altria company reports; ALCS S&BD estimates; other public company reports

  11. Slide 11: Share of 2013 U.S. Tobacco Industry Profits by Category

    Share of 2013 U.S. Tobacco Industry Profits by Category 80% 10% 6% 4% Cigarettes Smokeless Cigars Other Tobacco Source: Altria company reports; ALCS S&BD estimates; other public company reports

  12. Slide 12: Cigarette Category Decline Rate Estimates

    Cigarette Category Decline Rate Estimates Primarily due to FET increase (3.5)% (3.0)% (4.0)% (4.0)% (4.0)% (5.0)% (8.0)% 2007 2008 2009 2010 2011 2012 2013 Although cigarette volumes continue to decline, the rate of decline has held steady at 3 to 4% for many years. Source: ALCS MICR Estimates

  13. Slide 13: Tobacco Categories' Volume – 2010 to 2013 CAGR

    Tobacco Categories’ Volume – 2010 to 2013 CAGR ~5% ~3% ~(1)% ~(3.5)% Total Tobacco* Cigarettes Machine-made Smokeless Products Large Cigars * Total tobacco in pounds Source: ALCS MICR estimates based on TTB data through September 2013, cigarettes, small cigars based on 0.0325 oz/stick; ALCS MICR est

  14. Slide 14: Largest Consumer Products Categories

    Largest Consumer Products Categories 2013 U.S. Dollar Sales in Major Retail Channels $ in Billions $70 $66 $30 $28 $20 $0 Cigarettes Beer / Cider Carbonated Salty Beverages Snacks Note: Total US MOC is comprised of Food, Drug, Mass Merchandisers, Club, Dollar, DeCA, Convenience and Walmart classes o

  15. Slide 15: Category Growth – 2009 to 2013 CAGR

    Category Growth – 2009 to 2013 CAGR U.S. Dollar Sales in Major Retail Channels 7.2% 4.0% 3.2% (0.7)% Smokeless Beer/Cider Carbonated Salty Tobacco Beverages Snacks Note: Total US MOC is comprised of Food, Drug, Mass Merchandisers, Club, Dollar, DeCA, Convenience and Walmart classes of trade with ACV

  16. Slide 16: Manufacturers' Share of the 2013 U.S. Tobacco Profit Pool

    Manufacturers’ Share of the 2013 U.S. Tobacco Profit Pool 51% 22% 14% 13% Altria Reynolds American Lorillard Other Note: Altria’s Profit Pool share is calculated by combining the adjusted OCI* for Altria’s Smokeable & Smokeless Products segments divided by Total Profit Pool. *For reconciliation of n

  17. Slide 17: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  18. Slide 18: Marlboro – 2013 Retail Share

    Marlboro – 2013 Retail Share 43.7% Next 10 Largest Brands = 42.2% Marlboro Source: IRI/MSAi

  19. Slide 19: Smokeless – 2013 Retail Share

    Smokeless – 2013 Retail Share This space is blank because brand images which appeared in the original presentation 50.7% have been removed. Copenhagen & Skoal Source: IRI InfoScan

  20. Slide 20: Machine-Made Large Cigars – 2013 Retail Share

    Machine-Made Large Cigars – 2013 Retail Share 29.2% This space is blank because brand images which appeared in the original presentation have been removed. Black Black & Mild & Competitive Brands Mild Source: IRI InfoScan

  21. Slide 21: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  22. Slide 22: Smokeable Products Companies' Strategy

    Smokeable Products Companies’ Strategy Maximize income while maintaining modest share momentum on Marlboro and Black & Mild over time.

  23. Slide 23: Cigarette Category Income Drivers

    Cigarette Category Income Drivers • Pricing • Cost management This space is blank because • Retail share performance brand images which appeared • Equity-building activities in the original presentation • Product innovation have been removed.

  24. Slide 24: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  25. Slide 25: Marlboro Long-Term Retail Share Growth

    Marlboro Long-Term Retail Share Growth 50 43.7% 0 1954 1959 1964 1969 1974 1979 1984 1989 1994 1999 2004 2009 2013 Source: Maxwell; MSAi Shipments; IRI/Capstone – Total Retail Panel; IRP IRI Group/Capstone Projected Retail Panel; IRI/MSAi

  26. Slide 26: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  27. Slide 27: Marlboro Product Expansions

    Marlboro Product Expansions This space is blank because brand images which appeared in the original presentation have been removed.

  28. Slide 28: Marlboro Adult Smoker Engagement – Retail

    Marlboro Adult Smoker Engagement – Retail This space is blank because brand images which appeared in the original presentation have been removed.

  29. Slide 29: Marlboro Adult Smoker Engagement – Direct Mail

    Marlboro Adult Smoker Engagement – Direct Mail This space is blank because brand images which appeared in the original presentation have been removed.

  30. Slide 30: Marlboro Adult Smoker Engagement – Digital

    Marlboro Adult Smoker Engagement – Digital This space is blank because brand images which appeared in the original presentation have been removed.

  31. Slide 31: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  32. Slide 32: Marlboro Black is growing share

    Marlboro Black is growing share This space is blank because and building a brand images which appeared strong position, including with 21 in the original presentation to 29 year-old have been removed. smokers.

  33. Slide 33: Marlboro Digital Engagement

    Marlboro Digital Engagement Marlboro.com is among the largest CPG websites in This space is blank because the U.S. based on brand images which appeared average number of unique adult in the original presentation visitors age 21+. have been removed. comScore, 2013

  34. Slide 34: Marlboro Adult Smoker Connections

    Marlboro Adult Smoker Connections ~+50% This space is blank because brand images which appeared in the original presentation have been removed. 2011 2013 Source: PM USA

  35. Slide 35: Marlboro's Modest Retail Share Momentum

    Marlboro’s Modest Retail Share Momentum Average Annual Growth = ~0.2pp 42.9% 43.7% This space is blank because brand images which appeared in the original presentation have been removed. 2008 2013 Note: _____________________________________________________________________________ Source: ___________

  36. Slide 36: Pricing Considerations

    Pricing Considerations  Economic conditions  Price gaps  Competitive dynamics PM USA carefully manages its pricing to deliver long-term income growth.

  37. Slide 37: Pricing Considerations – Economic Conditions

    Pricing Considerations – Economic Conditions  Employment rates  Housing starts  Consumer confidence PM USA continuously monitors key indicators to understand the conditions of adult smokers.

  38. Slide 38: Pricing Considerations – Price Gap

    Pricing Considerations – Price Gap $6.50 Marlboro Net Price $5.86 Price Gap = ~35% $4.27 $4.38 Lowest Effective Price $3.04 $0.00 2009 2010 2011 2012 2013 Note: Marlboro excludes Marlboro 72mm Lowest = Actual Lowest Effective Pack Price (without PM USA Premium) Source: IRI/Capstone Pricing Database;

  39. Slide 39: Pricing Considerations – Competitive Dynamics

    Pricing Considerations – Competitive Dynamics Leading Premium Premium Cigarettes Segment Domestic Cigarette Brands 75% 75% 61.2% 63.8% 2009 2013 2009 2013 Source: IRI/MSAi Cigarettes 2013 – Total US Blended Share

  40. Slide 40: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  41. Slide 41: Middleton's Retail Share

    Middleton’s Retail Share Average Annual Decline = ~0.6pp 31.7% 29.4% 2009 2013 In a competitive environment, Middleton has focused on income growth, while managing share performance. Note: The IRI InfoScan 2013 service was implemented to read market share in 2011 and beyond. Share in 2009-2010 refle

  42. Slide 42: Smokeable Products Income Growth

    Smokeable Products Income Growth Adjusted OCI* $ in Billions $7.5 +4.2% CAGR $6.4 $5.2 $0.0 2008 2013 *For reconciliation of non-GAAP to GAAP measures visit altria.com Source: Altria company reports

  43. Slide 43: Smokeless Products Companies' Strategy

    Smokeless Products Companies’ Strategy Increase income by growing volume at or ahead of the category growth rate, while maintaining modest share momentum on Copenhagen and Skoal combined

  44. Slide 44: Smokeless Products Segment Performance

    Smokeless Products Segment Performance Smokeless Products Copenhagen & Skoal Shipment Volume Combined Retail Share +5.1% ~+0.9pp/yr CAGR average 788 50.7% 47.3% 646 2009 2013 2009 2013 Note: Reported domestic shipment volume for USSTC and PM USA cans and Note: The IRI InfoScan 2013 service was imple

  45. Slide 45: Copenhagen and Skoal Retail Share

    Copenhagen and Skoal Retail Share 60% 50.7% 47.3% 40% 21.4% 24.8% 20% 29.3% 22.5% 0% 2009 2013 Copenhagen Skoal Note: The IRI InfoScan 2013 service was implemented to read market share in 2011 and beyond. Share in 2009-2010 reflects estimates based on share changes derived from 2009-2010 IRI InfoSca

  46. Slide 46: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  47. Slide 47: Copenhagen's Share of Natural Segment

    Copenhagen’s Share of Natural Segment 100% 75% This space is blank because 50% brand images which appeared in the original presentation 25% have been removed. 0% Natural Segment Source: IRI Group InfoScan Smokeless Tobacco Database (FY 2012 – Retail Share) Source: IRI InfoScan Retail Share FY 2013

  48. Slide 48: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  49. Slide 49: Copenhagen Wintergreen Retail Share

    Copenhagen Wintergreen Retail Share 10% This space is blank because 5% brand images which appeared in the original presentation have been removed. 0% 2009 2011 2013 Note: The IRI InfoScan 2013 service was implemented to read market share in 2011 and beyond. Share in 2009-2010 reflects estimates base

  50. Slide 50: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  51. Slide 51: Skoal Classic and X-TRA

    Skoal Classic and X-TRA This space is blank because brand images which appeared in the original presentation have been removed.

  52. Slide 52: Skoal Share Performance and Price Gap

    Skoal Share Performance and Price Gap Skoal Retail Share 2013 Price Per Can 30% $6 55% price gap 24.8% 21.4% 20% $4 10% $2 0% $0 2009 2013 Classic Leading Discount Note: The IRI InfoScan 2013 service was implemented to read market share in 2011 and beyond. Share in 2009-2010 reflects estimates based

  53. Slide 53: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  54. Slide 54: "80 Days of Saturdays"

    “80 Days of Saturdays” Website Direct Mail This space is blank because brand images which appeared in the original presentation have been removed.

  55. Slide 55: Smokeless Products Adjusted OCI

    Smokeless Products Adjusted OCI* $ in Millions $1,200 +12.9% CAGR $1,026 $632 $600 $0 2009 2013 *For reconciliation of non-GAAP to GAAP measures visit altria.com Source: Altria company reports

  56. Slide 56: Altria's Tobacco Businesses

    Altria’s Tobacco Businesses

  57. Slide 57: Agenda

    Agenda  Maximizing income from our core tobacco businesses  Approach to innovation  Diverse business model and strong balance sheet  Regulatory capabilities  Delivering shareholder returns

  58. Slide 58: Innovation approach: expertise, acquisitions, third-party agreements

     Deep expertise and Altria service companies’ scale  Acquire complementary products, technologies and capabilities  Third-party agreements

  59. Slide 59: U.S. E-Vapor Consumer Expenditures

    U.S. E-Vapor Consumer Expenditures $ in Billions $1.5 +80% CAGR ~$1.0 $0.5 $0.3 $0.0 2011 2012 2013 Source: ALCS MICR estimates

  60. Slide 60: E-Vapor Awareness and Trial

    E-Vapor Awareness and Trial Awareness Trial* ~90% 63% 39% 28% November 2013 November May November 2012 2013 2013 Source: ALCS/MICR e-Cigarette Awareness & Usage Study among Adult Smokers 21-54 * Among Adult smokers aware of e-cigarettes

  61. Slide 61: E-Vapor Category Growth

    E-Vapor Category Growth  Product innovation  Regulation  Taxation Many adult smokers and vapers are still looking for a product that meets their requirements and desires.

  62. Slide 62: Nu Mark's Goal and Approach

    Nu Mark’s Goal and Approach  Launched MarkTen e-cigarettes in Indiana and Arizona  Announced the agreement to acquire the e-vapor business of Green Smoke  Signed agreements with Philip Morris International (PMI) Nu Mark’s goal is to achieve leadership in the U.S. e-vapor category.

  63. Slide 63: MarkTen Expansion

    MarkTen Expansion This space is blank because brand images which appeared in the original presentation have been removed. Nu Mark plans to expand MarkTen e-cigarettes nationally beginning in Q2 2014.

  64. Slide 64: Creating a Path to E-Vapor Leadership

    Creating a Path to E-Vapor Leadership  Product superiority and innovation  Premium brand building  Distribution and customer partnerships  Supply chain capability  Regulatory and government affairs capability

  65. Slide 65: MarkTen E-Cigarettes

    MarkTen E-Cigarettes Indiana – August 2013  First MarkTen test market Arizona – December 2013  Improved flavor systems for Classic and Menthol  USB charger added to single unit pack

  66. Slide 66: MarkTen Distribution in Arizona

    MarkTen Distribution in Arizona ~1,900 stores This space is blank because brand images which appeared in the original presentation have been removed. Note: As of January 28, 2014 Source: STARS Cigarette & e-Cigarette report ending 11/23/13; coverage represents YTD volume

  67. Slide 67: MarkTen Test Market

    MarkTen Test Market Retail Cartridge Share % 60 48% This space is blank because Arizona brand images which appeared in the original presentation 0 have been removed. Week 0 for MarkTen AZ - 12-15-13 Source: IRI InfoScan TDN Projected Retail Database ending 02/02/2014, (4-week moving average)

  68. Slide 68: Green Smoke

    Green Smoke  Agreement to acquire the e-vapor business of Green Smoke, Inc. for ~$110 million  Manufacturing and marketing high-quality, premium products since 2009  Expands Nu Mark’s product portfolio, including a larger product format and a new brand  Expect the transaction to be completed by

  69. Slide 69: Altria Strategic Agreements with PMI

    Altria Strategic Agreements with PMI  Exclusive license to PMI to commercialize e-vapor products internationally  Cooperation on regulatory engagement  Contract manufacturing arrangements

  70. Slide 70: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  71. Slide 71: Agreements on PMI Next Generation Products

    Agreements on PMI Next Generation Products  Exclusive U.S. license to Altria to sell two of PMI’s heated tobacco products  Cooperation on regulatory engagement related to heated tobacco products Our agreements with PMI support Altria’s broader strategy to create a robust portfolio of innovative pr

  72. Slide 72: Agenda

    Agenda  Maximizing income from our core tobacco businesses  Approach to innovation  Diverse business model and strong balance sheet  Regulatory capabilities  Delivering shareholder returns

  73. Slide 73: Diverse Business Model Delivers Financial Objectives

    Diverse Business Model Delivers Financial Objectives 27% Economic Interest Note: Third party trademarks are the property of their respective owners and are included for informational purposes only.

  74. Slide 74: Smokeable Products Segment Performance

    Smokeable Products Segment Performance Net Revenue per 1000* Adjusted OCI * - $ in Billions Adjusted OCI Margins* +5.2% +4.2% +8.4pp CAGR CAGR $6.4 42.2% $116.60 $5.2 $90.46 33.8% 2008 2013 2008 2013 2008 2013 Note: Net of FET *For reconciliation of non-GAAP to GAAP measures visit altria.com Source:

  75. Slide 75: Smokeless Products Segment Performance

    Smokeless Products Segment Performance Smokeless Products Copenhagen & Skoal Shipment Volume Combined Retail Share Adjusted OCI* - $ in Millions +5.1% ~+0.9pp/yr +12.9% CAGR average CAGR 788 50.7% $1,026 646 47.3% $632 2009 2013 2009 2013 2009 2013 Note: Reported domestic shipment volume for USSTC a

  76. Slide 76: Cost Management

    Cost Management  Altria delivered ~$2 billion in productivity savings  PM USA has efficiently managed costs

  77. Slide 77: Cost Management

    Cost Management Smokeable Products Controllable Costs/1000* FETRA Expense - $ in Millions +0.6% CAGR ~$400 $27.81 $28.69 ~$300 $0 2008 2013 2013 2014 2015 * For reconciliations of non-GAAP to GAAP measures visit www.altria.com Note: FETRA refers to the Fair and Equitable Tobacco Reform Act of 2004 S

  78. Slide 78: Altria's Alcohol Interests

    Altria’s Alcohol Interests This space is blank because brand images which appeared in the original presentation have been removed. Note: Third party trademarks are the property of their respective owners and are included for informational purposes only. Note: Third party trademarks are the property

  79. Slide 79: This space is blank because brand images which appeared in the original presentation have

    This space is blank because brand images which appeared in the original presentation have been removed.

  80. Slide 80: SABMiller Delivers Strong Income Growth

    SABMiller Delivers Strong Income Growth Equity Earnings - $ in Millions Market Value - $ in Billions +16.2% CAGR $991 $19.4 $467 $7.3 2008 2013 December 2008 January 2014 Source: Altria company reports Source: Bloomberg

  81. Slide 81: Ste. Michelle Wine Estates 90+ Ratings

    Ste. Michelle Wine Estates 90+ Ratings 221 193 187 159 “Winery of 2010 2011 2012 2013 the Year” for the 19th time Note: Third party trademarks are the property of their respective owners and are included for informational purposes only. Source: Altria company reports

  82. Slide 82: Ste. Michelle Wine Estates

    Ste. Michelle Wine Estates Adjusted OCI* - $ in Millions +12.8% CAGR $118 $73 2009 2013 * For reconciliations of non-GAAP to GAAP measures visit www.altria.com Source: Altria company reports

  83. Slide 83: Progress Unwinding PMCC Business

    Progress Unwinding PMCC Business Net Finance Receivable - $ in Billions $9.4 $5.7 $2.0 2002 2008 2013 Note: Net Finance Receivables reflects PMCC’s investments in finance leases excluding the allowance for losses. Source: Altria company reports

  84. Slide 84: PMCC Income Contribution

    PMCC Income Contribution Year-end Portfolio - # of Assets Adjusted OCI* - $ in Millions Lease Income, Other (Primarily net of expenses Gains from Asset Sales) $289 61 55 $238 49 38 $183 $157 $141 29 2009 2010 2011 2012 2013 2009 2010 2011 2012 2013 *For reconciliations of non-GAAP to GAAP measures v

  85. Slide 85: Altria's Strong Balance Sheet

    Altria’s Strong Balance Sheet  Provides stability and liquidity  Supports Altria’s investment grade credit rating  Enhances ability to return cash to shareholders

  86. Slide 86: 2012-2013 Capital Markets Activities

    2012-2013 Capital Markets Activities  Tendered for high-coupon debt  Replaced with lower cost debt  Improved debt maturity profile  Lowered future interest expense

  87. Slide 87: Reduced Weighted Average Coupon Rate

    Reduced Weighted Average Coupon Rate (3.2)pp 9.1% 5.9% December 2009 December 2013 Source: ALCS Finance

  88. Slide 88: Altria's Strong Dividend

    Altria’s Strong Dividend Annualized Dividend Current Dividend Yield +8.8% CAGR 5.4% $1.92 $1.16 2.7% 2.1% 2007 2013 Altria 10-yr UST S&P 500 Note: Annualized rate: 6-year CAGR assumes the post-PMI spin-off dividend Note: As of February 14, 2014 of $0.29 per common share was the end of 2007 dividend

  89. Slide 89: Share Repurchase Programs

    Share Repurchase Programs  ~$4.2 billion in shares repurchased since PMI spin-off  ~$540 million in shares repurchased through end of 2013  Current $1 billion repurchase program  Expect to complete program by end of Q3 2014  Timing of share repurchases depends upon marketplace conditions and ot

  90. Slide 90: Diverse Business Model

    Diverse Business Model 27% Economic Interest Note: Third party trademarks are the property of their respective owners and are included for informational purposes only.

  91. Slide 91: Altria's Consistent EPS Growth

    Altria’s Consistent EPS Growth Adjusted Diluted EPS* - YOY % Change 9.3% 8.6% 7.9% 7.8% 7.7% 6.1% 2008 2009 2010 2011 2012 2013 * For reconciliation of non-GAAP to GAAP measures visit altria.com Source: Altria company reports

  92. Slide 92: 2014 Guidance

    2014 Guidance  Altria reaffirms it expects its 2014 full-year adjusted diluted EPS* to increase by 6% to 9% to a range of $2.52 to $2.59 from its 2013 adjusted diluted EPS base of $2.38 per share. * For reconciliation of non-GAAP to GAAP measures visit altria.com Source: Altria company reports

  93. Slide 93: 2014 Guidance

    2014 Guidance  Core tobacco businesses are positioned to deliver strong income growth  Benefit from lower interest expense, a lower effective tax rate and a reduction in shares from the current share repurchase program  Plan to continue making investments to build Nu Mark’s e-vapor business  Exp

  94. Slide 94: Agenda

    Agenda  Maximizing income from our core tobacco businesses  Approach to innovation  Diverse business model and strong balance sheet  Regulatory capabilities  Delivering shareholder returns

  95. Slide 95: Experience

    Experience Note: Third party trademarks are the property of their respective owners and are included for informational purposes only.

  96. Slide 96: Strong Regulatory Capabilities

    Strong Regulatory Capabilities  Building a constructive and enduring relationship with FDA  Compliance  Engagement and advocacy

  97. Slide 97: Altria's Engagement with FDA

    Altria’s Engagement with FDA  Docket submissions  Meetings with FDA  TPSAC Presentations  Public workshops  Published scientific papers  Presentations at scientific conferences

  98. Slide 98: Altria's Compliance Efforts

    Altria’s Compliance Efforts  Registering manufacturing facilities  Listing of our companies’ tobacco products  Submitting ingredient information  Inspections of our registered facilities  Hosting FDA at our facilities  Conducting internal regulatory training

  99. Slide 99: Regulatory Update – Substantial Equivalence

    Regulatory Update – Substantial Equivalence  FDA has said substantial equivalence is a priority  Applications pending for in-market products and products not yet introduced

  100. Slide 100: Regulatory Update – Menthol

    Regulatory Update – Menthol  Comments submitted to FDA - November 2013  Menthol cigarettes do not affect population harm differently than non- menthol cigarettes  FDA is reviewing nearly 200,000 stakeholder comments “The science- and evidence-based information continues to demonstrate that regula

  101. Slide 101: Regulatory Update – Deeming

    Regulatory Update – Deeming  According to the FDA, deeming regulations likely to be issued soon  Being reviewed by OMB  Altria met with FDA to discuss regulation of all tobacco products

  102. Slide 102: Support for Deeming Regulation

    Support for Deeming Regulation  Framework to evaluate tobacco products that are potentially less harmful  Clear principles for accurate and scientifically grounded communications We support FDA’s efforts to extend its regulatory authority to all tobacco products.

  103. Slide 103: Deeming Regulation

    Deeming Regulation  Registration These “general  Product listing controls” should help  Ingredient listing establish common standards for all U.S.  Good manufacturing practice requirements manufacturers and importers of deemed products. Note: _____________________________________________________

  104. Slide 104: Harm Reduction Framework

    Harm Reduction Framework  Advance public health goals  Recognize product differences  Foster innovation  Grounded in science and evidence

  105. Slide 105: Anticipated FDA Developments in 2014

    Anticipated FDA Developments in 2014  Deeming regulation  Menthol  Substantial equivalence  TPSAC appointments  Advertising and communications Note: Third party trademarks are the property of their respective owners and are included for informational purposes only.

  106. Slide 106: Altria's Regulatory Capabilities

    Altria’s Regulatory Capabilities  Building a constructive and enduring relationship with FDA  Compliance  Engagement and advocacy We’ve built strong capabilities to help our tobacco companies successfully compete under FDA regulation.

  107. Slide 107: Agenda

    Agenda  Maximizing income from our core tobacco businesses  Approach to innovation  Diverse business model and strong balance sheet  Regulatory capabilities  Delivering shareholder returns

  108. Slide 108: Altria's Strategies

    Altria’s Strategies Maximize income from core premium tobacco businesses over the long term Grow new income streams with innovative products Manage diverse income streams and strong balance sheet to deliver consistent financial performance

  109. Slide 109: Creating Shareholder Value

    Creating Shareholder Value Altria Adjusted Diluted EPS* S&P 500 Operating EPS +7.9% +4.6% CAGR $2.38 CAGR $108.28 $82.54 $1.51 2007 2013 2007 2013E *For reconciliations of non-GAAP to GAAP measures visit www.altria.com Note: S&P 500 Operating EPS includes income from product (goods and services), bu

  110. Slide 110: Dividend Yield

    Dividend Yield 5.4% 2.1% Altria S&P 500 Source: Bloomberg

  111. Slide 111: Six-Year Total Shareholder Return

    Six-Year Total Shareholder Return 137% 91% 44% Altria Group S&P Food, Beverage S&P 500 and Tobacco Index Note: Total shareholder return is simple price appreciation plus the reinvestment of the dividend as of the ex-dividend date (12/31/2007 to 12/31/2013). Source: Bloomberg Daily Return

  112. Slide 112: Slide 112

  113. Slide 113: Slide 113

  114. Slide 114: Regulation G Disclosure

    Regulation G Disclosure  For reconciliations and further explanations of non-GAAP financial measures, visit: altria.com

  115. Slide 115: Slide 115

Altria Group — CAGNY Conference 2014 on 6ix